Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Findlay

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
European Radiology|January 16, 2019
Routinely staging gastric cancer with <sup>18</sup>F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgeryJohn M Findlay, Stefan Antonowicz, Ashvina Segaran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized TherapyJohn M Findlay, Kevin M Bradley, Lai Mun Wang, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 18, 2021
A multicenter prospective audit to investigate the current management of patients undergoing anti-reflux surgery in the UK: Audit & Review of Anti-Reflux Operations & Workup, Rob Walker, Tom Wiggins, et al.
European Radiology|February 18, 2016
Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgeryJohn M Findlay, Richard S Gillies, James M Franklin, et al.
Nature Communications|April 6, 2016
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapyJohn M Findlay, Francesc Castro-Giner, Seiko Makino, et al.
Gastroenterology|December 3, 2014
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagusClaire Palles, Laura Chegwidden, Xinzhong Li, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
European Radiology|January 16, 2019
Routinely staging gastric cancer with <sup>18</sup>F-FDG PET-CT detects additional metastases and predicts early recurrence and death after surgeryJohn M Findlay, Stefan Antonowicz, Ashvina Segaran, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 17, 2016
Predicting Pathologic Response of Esophageal Cancer to Neoadjuvant Chemotherapy: The Implications of Metabolic Nodal Response for Personalized TherapyJohn M Findlay, Kevin M Bradley, Lai Mun Wang, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 18, 2021
A multicenter prospective audit to investigate the current management of patients undergoing anti-reflux surgery in the UK: Audit & Review of Anti-Reflux Operations & Workup, Rob Walker, Tom Wiggins, et al.
European Radiology|February 18, 2016
Restaging oesophageal cancer after neoadjuvant therapy with (18)F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgeryJohn M Findlay, Richard S Gillies, James M Franklin, et al.
Nature Communications|April 6, 2016
Differential clonal evolution in oesophageal cancers in response to neo-adjuvant chemotherapyJohn M Findlay, Francesc Castro-Giner, Seiko Makino, et al.
Gastroenterology|December 3, 2014
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagusClaire Palles, Laura Chegwidden, Xinzhong Li, et al.
Pageof 7